Overview
Ken Tajima practices practicing medicine in Tokyo, Japan.
Mr. Tajima is highly rated in 1 condition, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Tracheobronchopathia Osteoplastica, and EGFR Positive Lung Cancer.
He is actively involved in clinical research, co-authoring 32 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ken Tajima
Is Ken Tajima a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Ken Tajima is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ken Tajima participate in research or clinical trials?
Yes. Ken Tajima has published 32 articles and abstracts on conditions like Lung Cancer. You can view a list of Ken Tajima's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMr. Tajima isAdvanced. Learn about Lung Cancer.
- Experienced
- Cerebral HypoxiaMr. Tajima isExperienced. Learn about Cerebral Hypoxia.
- EGFR Positive Lung CancerMr. Tajima isExperienced. Learn about EGFR Positive Lung Cancer.
- Neuroendocrine TumorMr. Tajima isExperienced. Learn about Neuroendocrine Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Tajima isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pulmonary FibrosisMr. Tajima isExperienced. Learn about Pulmonary Fibrosis.
- Small Cell Lung Cancer (SCLC)Mr. Tajima isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Thymic Epithelial TumorMr. Tajima isExperienced. Learn about Thymic Epithelial Tumor.
- Tracheobronchopathia OsteoplasticaMr. Tajima isExperienced. Learn about Tracheobronchopathia Osteoplastica.